Gynecological Cancer News Articles Provided by Cancer Compass
|
|
07/19/2010 New Study Finds HPV Vaccine Protects Against Genital Warts Post-marketing research shows some serious side effects, but most are controllable Read more at this website... 07/01/2010 Be An Open-minded Skeptic; Consider A Wide Array Of Integrative Medicine Choices Integrative medicine focuses on mind, body and spirit, combining today's cutting-edge treatments with nontraditional techniques and approaches. The June issue of Mayo Clinic Health Letter features an in-depth Special Report on this rapidly growing area of medicine, covering mind-body, energy and hands-on therapies. Read more at this website... 06/24/2010 Recent Findings In Ovarian Cancer Described By Researchers From University Of The Sacred Heart Research findings, 'Review role of topotecan in gynaecological cancers: current indications and perspectives,' are discussed in a new report. Ovarian cancer is the fourth cause of death from gynaecological cancer and cervical cancer is the first in women Critical Reviews In Oncology report. Read more at this website... 06/24/2010 New Research On Ovarian Cancer From University Of Toronto Scientists discuss in 'Continuous docetaxel chemotherapy improves therapeutic efficacy in murine models of ovarian cancer' new findings in ovarian cancer. Read more at this website... 06/24/2010 Study Findings On Cervical Cancer Are Outlined In Reports From University Of Ulsan Fresh data on cervical cancer are presented in the report 'Fertility-sparing laparoscopic radical trachelectomy for young women with early stage cervical cancer.' Read more at this website... 06/24/2010 Research On Cervical Cancer Described By Scientists At University Of Amsterdam The aim of this study was to determine prevalence of and experienced distress from pelvic floor symptoms in cervical cancer survivors (CCS). Read more at this website... 06/24/2010 New Route To Killing Cancer Gets A Test Run A targeted therapy that has generated excitement for its early success in breast cancer is now being tested in the Triangle on other cancers, including often-deadly ovarian tumors. Doctors and patients have eagerly anticipated the drugs, which provide an entirely new route to killing tumors that is less toxic than traditional chemotherapies. Read more at this website... 07/15/2010 Hopes Dashed That Vitamin D Reduces Cancer Risk Researchers did find those with high levels more likely to develop pancreatic cancer Read more at this website... 06/17/2010 Researchers From University Of California Report Recent Findings In Cervical Cancer Current study results from the report, 'The rationale for the use of non-platinum chemotherapy doublets for metastatic and recurrent cervical carcinoma,' have been published. According to a study from the United States, Ongoing drug discovery and synergy in cytotoxic combinations have served as the dominant theme for clinical research in women with metastatic and recurrent cervical cancer. Read more at this website... 06/17/2010 Late-Stage Ovarian Cancer Shows Promise In Two-Drug Phase I Trial The combination of decitabine and carboplatin appears to improve the outcome of women who have late-stage ovarian cancer. In an upcoming issue of the journal Cancer (online today), Indiana University researchers report four of 10 patients who participated in a phase I clinical trial had no disease progression after six months of treatment. One patient experienced complete resolution of tumor tissue for a period of time. Read more at this website... 06/17/2010 New AMG 386 Data Demonstrate Promising Antitumor Activity In Patients With Recurrent Ovarian Cancer Amgen announced that AMG 386, combined with paclitaxel, demonstrated antitumor activity in a randomized Phase 2 trial involving 161 patients with recurrent ovarian cancer. The results are being presented for the first time in an oral presentation at the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting. Read more at this website... 06/17/2010 Government Moves To Oversee Genetic Tests Aimed At Consumers During a stay at a resort two years ago, Carol Arand purchased $4,000 in genetic tests after a spa physician praised their potential to improve her health. If ever she got sick, Arand reasoned, she could take the results to her doctor. I hoped that this genetic fingerprint could be useful, she said. Read more at this website... 06/17/2010 New Genomic Cancer Care Alliance Formed To Study Whole-Genome Sequencing In Cancer Treatment Life Technologies Corporation (NASDAQ: LIFE) announced the creation of the Genomic Cancer Care Alliance to help people battling cancer gain access to treatment options found through analysis of their genomic information. Founding partners include Fox Chase Cancer Center, Scripps Genomic Medicine, and the Translational Genomics Research Institute (TGen).The announcement came during the Consumer Genetics Conference being held June 2-4 in Boston. Read more at this website... 06/17/2010 Blood-Sugar Lowering Medications May Increase Risk For False Positive Results In Cancer Screenings A study presented at SNM's 57th Annual Meeting suggests that medication ingested to control blood-sugar levels can skew the results of cancer screenings using positron emission tomography (PET), a molecular imaging technique, by increasing absorption in the gut of the PET imaging agent called fluorodeoxyglucose (18F- FDG), which mimics sugar inside the body. Read more at this website... 06/17/2010 Do Doctors Screen For Cervical Cancer Too Often? It sounds like the breast- cancer debate all over again: A new study has found that doctors have been overzealous in advising women to be screened for cervical cancer. Although physician groups and federal guidelines recommend that women older than 30 get a Pap test every three years, a survey of more than 1,200 doctors in the Journal of the American Medical Association released Monday found that about two-thirds would recommend that patients be screened more often. Read more at this website... 07/15/2010 Most Doctors Giving Pap Test Too Often But that doesn't mean women should skip gynecological exam, experts say Read more at this website... 06/11/2010 Abbott Receives FDA Clearance for New Ovarian Cancer Test The U.S. Food and Drug Administration (FDA) has cleared a new diagnostic test to monitor ovarian cancer, a disease that will strike an estimated one out of every 71 women in the United States in their lifetimes. Abbott's new ARCHITECT HE4 (human epididymis protein 4) assay, the first automated test of its kind available in the United States, uses a simple blood test to aid in monitoring for the recurrence or progression of this disease. Read more at this website... 06/11/2010 Results From A Study Testing Methylphenidate For Cancer-Related Fatigue Indicate That It Is Certainly Not A Panacea But May Be Effective For Some Groups Of Patients Cancer-related fatigue is often a major problem for cancer patients, beginning at diagnosis, during treatment and after completing therapy. Researchers at Mayo Clinic and the North Central Cancer Treatment Group (NCCTG) recently completed a study testing methylphenidate in the treatment of cancer-related fatigue and found that, while it did not improve fatigue for a broad group of patients, the data did not rule out a benefit for those with stage III/IV cancer. Read more at this website... 06/11/2010 Research Conducted At University Of Arkansas For Medical Sciences, Medical Has Provided New Information About Obesity Researchers detail in 'Consideration of the food environment in cancer risk reduction,' new data in obesity. According to a study from the United States, Recently, there has been increased attention to the food environment's impact on chronic disease, specifically obesity and cardiovascular disease. Read more at this website... 06/11/2010 Late-Stage Ovarian Cancer Shows Promise In Two-Drug Phase I Trial The combination of decitabine and carboplatin appears to improve the outcome of women who have late-stage ovarian cancer. In an upcoming issue of the journal Cancer (online today), Indiana University researchers report four of 10 patients who participated in a phase I clinical trial had no disease progression after six months of treatment. One patient experienced complete resolution of tumor tissue for a period of time. Read more at this website... |
